Biotechnology from bench to business

• Follow GEN on:
• Login | Register | Subscribe

• ADME/Tox
• Automation
• Bioprocess Scale-Up
• Bioreactors
• Biosimilars
• Cell Culture
• Cell-Based Assays
• Contract Manufacturing
• Gene Therapy
• High-Throughput Screening
• Immunoassay
• Induced Pluripotent Stem Cells
• Informatics
• Liquid Handling
• Protein Characterization
• Protein Detection
• Regenerative Medicine
• RNAi/siRNA
• Stem Cells
• Western Blot

• GEN Articles

• More »

• Feature Articles: Mass Spec Provides Peek into PTMs
  
• Feature Articles: Cracking the PTM Code
  
• Feature Articles: Managing PTMs in Protein Therapeutics
  Ultimate Success of Biosimilars Linked to Adroit Handling of Post-Translational Modifications
• Feature Articles: Tandem MS Zooms In on Glycosylation
  Conventional Methods Are Inadequate When It Comes to Quantitative and Structural Analysis
• Feature Articles: PTMs Progress Toward Designer Proteins
  Advances in the Analysis and Biosynthesis of Glycans Are Transforming the Field

• Insight & Intelligence™

• More »

• Even More PTMs
  May 4, 2012
  Review of study points to relative abundance of PTMs in human cells.

• GEN News Highlights

• More »

• Siena Biotech Selects Proteome Sciences as Preferred Biomarker Service Provider
  
• Proteome Sciences and Buck Institute Ally on MS-Based Anti-Estrogen Therapy Resistance Assays
  
• Scientists Visualize Signaling-Triggered Protein Modifications and mRNA Production Simultaneously in Single Cells
  
• AstraZeneca Turns to Kinaxo to Study PTMs Related to an Oncology Program
  

• Webinars

• More »

• GEN Webinars: Heightened Characterization of Therapeutic mAbs Using a Novel Enzyme-Facilitated Middle-Down Approach